Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair

PURPOSE: Generally, aspirin is used as a protective agent against thrombogenic phenomenon after pulmonary valve replacement (PVR) using a bioprosthetic valve. However, the appropriate duration of aspirin use is unclear. We analyzed the impact of postoperative duration of aspirin use on the longevity...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Korean J Pediatr
Autors principals: Hwang, Tae-Woong, Kim, Sung-Ook, Lee, Sang-Yun, Kim, Seong-Ho, Choi, Eun-Young, Jang, So-Ick, Park, Su-Jin, Kwon, Hye-Won, Lim, Hyo-Bin, Lee, Chang-Ha, Choi, Eun-Seok
Format: Artigo
Idioma:Inglês
Publicat: The Korean Pediatric Society 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118504/
https://ncbi.nlm.nih.gov/pubmed/27895692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3345/kjp.2016.59.11.446
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars